Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
In the 1990s, researchers studying the Gila monster (Heloderma suspectum), a venomous lizard native to the southwestern United States and northwestern Mexico, made a groundbreaking discovery that would transform diabetes treatment
Mounjaro (Tirzepatide) A new class of GLP-1 medication that provides dual benefits for both diabetes and weight loss is of particular importance in people who do not necessarily have diabetes
The groups, led by the Alliance for Women's Health and Prevention, note in a letter that obesity is a chronic condition that costs employers approximately $425.5 billion annually
These drugs mimic the physiological effects of GLP-1 by binding to GLP-1R, which enhances insulin secretion, inhibits glucagon release, delays gastric emptying, and reduces food intake (Drucker, 2018)
